Build your foundation. Avoid costly mistakes. Get grounded in the essentials of export controls and compliance. This session covers the key regulations, common pitfalls (including dual-use items), and why compliance matters – because mistakes can carry serious consequences. Perfect for…
Justice: Former Logistics CEO Pleads Guilty to Export Law Violations Conspired to Ship Goods to Blacklisted Chinese Companies
Justice: Former Logistics CEO Pleads Guilty to Export Law Violations Conspired to Ship Goods to Blacklisted Chinese Companies
November 27, 2024/
Justice the former CEO of an international logistics / freight forwarding company plead guilty to conspiring to violate export laws by shipping goods to CN companies on the Entity List.
- This man knew that the company in CN changed their name to evade the entity list restrictions (from Seajet to Hisiang) because the company told them in an email
- A BIS person visited their office to tell them about the prohibition and educate them, and at a later date another official reached out to get a list of their prohibited companies (Seajet / Hisiang wasn't on that list).
Related Posts
Year-End Insights Webinar 3: How to Prepare for 2026
Strategies, Tools & Talent for What’s Next! During the session Star USA’s president, Michael D. Easton, opened with key takeaways from our previous webinar. Licensed Customs Broker DeAndra Ballard then walked through the fundamentals of tariffs. The webinar concluded with a look ahead to trade and compliance in 2026 and a Q&A session with the…
USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…
FDA: Agency Deploys Agentic AI Capabilities for Staff Use
The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority of staff-and introduce more advanced features for workflow automation, planning, and reasoning. Participation remains optional,…
CBP: Section 321 Enforcement Update in ACE to Block Ineligible De Minimis Shipments
CBP is enhancing Section 321 enforcement within ACE to ensure compliance with the $800 de minimis threshold. Starting June 26, the update will be deployed to the CERT environment. This enhancement will prevent the release of shipments claiming de minimis entry when the $800 per person per day limit has already been exceeded, helping to…